Form D — Neurofold Therapeutics Inc.
0002145237-26-000001 · filed Jul 14, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $6,499,987
- Reported amount sold
- $6,499,987
- Minimum investment
- $9,999
- Investors
- 18
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Neurofold Therapeutics Inc.
- CIK
- 2145237
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 5500 S. MARIGOLD COURT
GREENWOOD VILLAGE, CO 80121 - Phone
- 303-564-8817
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Rajeev Kumar · Executive OfficerGreenwood Village, CO Find on LinkedIn ↗
-
Gurdane Bhutani · DirectorClaymont, DE Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗